GlassScriptPhysician profile
Jeffrey Reeves
NPI 1093102170
$46,263.90
in general payments reported to CMS, 2019-2025
9 companies · $16K in 2025
The $16K reported for 2025 was more than what 80% of Adult Reconstructive Orthopaedic Surgery providers received nationally (typical 2025 total: $1,425).
See the full distribution for Adult Reconstructive Orthopaedic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $66.99 · 2020: $5,037 · 2021: $5,394 · 2022: $253 · 2023: $16K · 2024: $3,878 · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $24K · Travel and Lodging: $9,254 · Food and Beverage: $2,219 · Education: $89.68.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $23,950.00 |
| Travel and Lodging | $9,254.18 |
| Food and Beverage | $2,218.58 |
| Education | $89.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Think Surgical, INC. | $31,741.70 | 2023-2025 | |
| Smith+Nephew, INC. | $10,000.00 | 2020-2021 | |
| Stryker Corporation | $2,279.77 | 2020-2025 | Mako, Motionsense Digital Goniometer |
| Zimmer Biomet Holdings, INC. | $1,871.60 | 2022-2025 | Avenir, Persona, Rosa |
| Medacta USA, INC. | $133.45 | 2025 | Gmk Sphere |
| Depuy Synthes Sales INC. | $98.05 | 2025 | |
| Mallinckrodt Enterprises LLC | $66.99 | 2019 | |
| Medical Device Business Services, INC. | $38.94 | 2024 | Velys |
| Microport Orthopedics INC | $33.40 | 2024 | Mpo Medial Pivot Knee |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Reeves listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.